We’re partnering with life sciences companies to address gaps in care, one of the key steps in better managing population health and improving patient outcomes. It’s important to collaborate with all stakeholders – patients, providers, payers, life sciences and health IT companies – because that’s how we’ll succeed with value-based care.
How is Allscripts working with life sciences companies? Here are a few examples:
#1 – Are clinicians identifying enough patients who need clinical intervention? Allscripts has independently analyzed best-in-class guidelines that address gaps in care for certain therapeutic areas. Allscripts builds those guidelines into point-of-care alerts. Sponsored by life sciences companies, we are educating providers and practices about how to use the Allscripts alerts to close gaps in care for patients. We have partnerships in place to address rheumatoid arthritis, diabetes, asthma, vaccines, and other therapeutic areas. These programs will increase awareness of potential gaps in care so that the clinician can work efficiently to improve patient outcomes.
#2 – Do patients take their scripts to the pharmacy? About 30% of new prescriptions go unfilled. Clinicians can provide patients with patient-appropriate medication education at the point of prescribing. This education has the added benefit of serving as a reminder for patients to pick up their medications and helps physicians achieve credit for the Meaningful Use patient education measure, in addition to driving medication first-fill compliance.
#3 – Can patients afford their prescriptions? Clinicians receive an alert at the point of care if there are any coupon programs available for the medication they just prescribed. Clinicians can pass those savings along to the patient, which also increases the likelihood of first-fill compliance and adherence.
#4 – Will prior authorization (PA) delay access to medications for patients? Certain high-cost medications must be pre-authorized by a payer before a patient can receive them and PA requirements are growing every year. Today’s authorization process is often a lengthy, manual back-and-forth process among the doctor, payer, pharmacy and patient. According to Frost and Sullivan, about 70% of patients who encounter a manual paper-based PA do not receive the original prescription, and patients abandon about 40% of manual PAs. Our partnership with payers and life sciences companies enables physicians to obtain PA electronically, leading to faster patient access to medications and reduced rates of prescription abandonment.
#5 – Does the provider have relevant patient care information from other providers? Inclusion of the Payers Health Profile in the EHR will enable and expand the longitudinal view of a patient’s health record based on claims and other data aggregated by the payer from multiple providers.
These are just a few examples of how we’re helping clinicians close gaps in care. We have the largest network of providers using EHR technology and a large patient base through the FollowMyHealth® patient portal. Working with all stakeholders, we’ll enable clinicians to access the knowledge they need to transform health care as we know it.